Davini, F.; Fogolari, M.; D’Avanzo, G.; Ristori, M.V.; Nucciarelli, S.; Bani, L.; Cristiano, A.; De Cesaris, M.; Spoto, S.; Angeletti, S.
Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis. Diagnostics 2025, 15, 1010.
https://doi.org/10.3390/diagnostics15081010
AMA Style
Davini F, Fogolari M, D’Avanzo G, Ristori MV, Nucciarelli S, Bani L, Cristiano A, De Cesaris M, Spoto S, Angeletti S.
Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis. Diagnostics. 2025; 15(8):1010.
https://doi.org/10.3390/diagnostics15081010
Chicago/Turabian Style
Davini, Flavio, Marta Fogolari, Giorgio D’Avanzo, Maria Vittoria Ristori, Serena Nucciarelli, Lucrezia Bani, Antonio Cristiano, Marina De Cesaris, Silvia Spoto, and Silvia Angeletti.
2025. "Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis" Diagnostics 15, no. 8: 1010.
https://doi.org/10.3390/diagnostics15081010
APA Style
Davini, F., Fogolari, M., D’Avanzo, G., Ristori, M. V., Nucciarelli, S., Bani, L., Cristiano, A., De Cesaris, M., Spoto, S., & Angeletti, S.
(2025). Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis. Diagnostics, 15(8), 1010.
https://doi.org/10.3390/diagnostics15081010
